I. Nimmrich

发表

Epigenomics: genome-wide study of methylation phenomena.

S Beck, S. Beck, C. Piepenbrock, 2002, Current issues in molecular biology.

Oligonucleotide‐based microarray for DNA methylation analysis: Principles and applications

Tim Hui-Ming Huang, Huidong Shi, Charles W Caldwell, 2003, Journal of cellular biochemistry.

DNA methylation markers - an opportunity to further individualize therapy in breast cancer?

S. Maier, I. Nimmrich, F. Eckhardt, 2005, Personalized medicine.

Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP

I. Nimmrich, R. Kruse, W. Friedl, 1997, Human Genetics.

A β‐catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β‐catenin germline mutations in FAP patients

I. Nimmrich, O. Müller, W. Friedl, 1998, Genes, chromosomes & cancer.

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and

J. Foekens, J. Nährig, J. Martens, 2007, European journal of cancer.

Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis

Matthias Burger, B. Dörken, S. Maier, 2005, Annals of Hematology.

Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation.

S. Erdmann, I. Nimmrich, M. Renner, 2002, The Biochemical journal.

The novel ependymin related gene UCC1 is highly expressed in colorectal tumor cells.

S. Erdmann, I. Nimmrich, M. Oertel, 2001, Cancer letters.

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.

M. Beckmann, D. Wallwiener, N. Harbeck, 2012, Breast.

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

J. Foekens, J. Nährig, G. Kristiansen, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

John W. M. Martens, Manfred Schmitt, Nadia Harbeck, 2008, Breast Cancer Research and Treatment.

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial

C. Kropf-Sanchen, P. Schnabel, W. Engel-Riedel, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Seven genes that are differentially transcribed in colorectal tumor cell lines.

S. Erdmann, M. Moyer, I. Nimmrich, 2000, Cancer letters.

Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.

John W M Martens, Fabian Model, Christian Piepenbrock, 2005, Cancer research.

Patients with Recurrent Breast Cancer Aminotransferase with Response to Endocrine Therapy in Association of DNA Methylation of Phosphoserine

J. Foekens, J. Klijn, H. Höfler, 2005 .

The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas.

Huidong Shi, C. Caldwell, T. Huang, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Differential DNA methylation of gene promoters in small B-cell lymphomas.

Huidong Shi, C. Caldwell, T. Huang, 2005, American journal of clinical pathology.

Methylation discriminators in NSCLC identified by a microarray based approach.

T. Liloglou, S. Maier, I. Nimmrich, 2005, International journal of oncology.

A β‐catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β‐catenin germline mutations in FAP patients

I. Nimmrich, O. Müller, W. Friedl, 1998, Genes, chromosomes & cancer.